Trial Profile
A phase 1/2 study of safety, tolerability, and efficacy of TG01/QS-21 in patients with multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jul 2023
Price :
$35
*
At a glance
- Drugs TG 01 Targovax (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms Tg01-Study
- 28 Jul 2023 New trial record